retatrutide clinical trial safety Weight Loss Blog – Maryland Trim Clinic Retatrutide Availability & Timeline |

N., Abdelsalam, F., Marey, A., Tanas, Y., Belal, M

Patients with contraindicationsincluding personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe gastrointestinal diseaseshould not use GLP-1 medications

Standard (5 mg/mL) provides a balanced approach for most research scenarios

But over time, researchers discovered these medications regulate appetite and support gradual, sustainable weight loss

theyre simply another factor that may influence an already sensitive digestive system

At New Jersey Bariatric Center, we offer a comprehensive approach that pairs weight loss medications with exercise and nutrition support to help you build sustainable habits that help to minimize weight re-gain